The vaccine market represents an increasingly attractive segment characterized by promising vaccine candidates, rising global demand and preparations for the next pandemic influenza. Future potential of the vaccine market will be discussed at Jacob Fleming’s Next Generation Vaccines Conference, taking place in Vienna, Austria on 21st – 22nd October. The latest developments in the prophylactic and the therapeutic segment will be explored. Optimization of clinical trials performance, overcoming challenges in launching new vaccine candidates and much more will be discovered.
Delegates will have a chance to become a part of real-life case studies delivered by industry professionals of the best contract manufacturers and by the WHO’s Director of Vaccine Project Optimization who will reveal best practices of manufacturing and distribution.
Top vaccine experts such as Gerd Zettlmeissl, the CEO of Intercell and the winner of the Vaccine Industry Excellence Award of 2010, Danilo Casimiro, the Director of Viral Vaccine Research of Merck, Dr Farshad Guarikhoo, the Senior Director of External Research and Development of Sanofi Pasteur and Ed Geuns, the Head of Global Regulatory Affairs Liaison Vaccines of Abbott Biologicals will provide delegates with overall walkthrough of the whole Vaccine Value Chain.
The special feature of this event is an interactive Workshop day, held on 20th October. Workshop will include three unique sessions with a strong focus on accelerated process development, excellence in the proof-of concept clinical trials and vaccine manufacturing challenges.
How to obtain funding & financing for vaccines?
What are the main issues in establishing industry partnership?
And how to provide vaccination against influenza on a large scale?
All these and many other questions will be answered by Dr Jerald C. Sadoff, the experienced CMO of Crucell, Dr Hansi Dean and Dr Philip Dormitzer, the Head of the Viral Advanced Programs of Novartis.
For further information and to book your place at the event, please contact:
Peter Novak
T: +421 257 272 110
E: peter.novak@jacobfleming.com
W: www.jacobfleming.com
If you would like to make a comment, please fill out the form below.
Featured Reports
